Liabilities and Equity in USD of Channel Therapeutics Corp from Q4 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Channel Therapeutics Corp quarterly Liabilities and Equity history and change rate from Q4 2022 to Q3 2025.
  • Channel Therapeutics Corp Liabilities and Equity for the quarter ending 30 Sep 2025 was $126M, a 5808% increase year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

Channel Therapeutics Corp Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $126M +$124M +5808% 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 $823K -$1.78M -68.4% 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 $911K -$3.12M -77.4% 31 Mar 2025 10-Q 13 May 2025
Q4 2024 $1.37M +$1.27M +1320% 31 Dec 2024 10-Q 13 Nov 2025
Q3 2024 $2.14M 30 Sep 2024 10-Q 13 Nov 2024
Q2 2024 $2.6M 30 Jun 2024 10-Q 13 Aug 2024
Q1 2024 $4.03M 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $96.4K +$41.3K +75% 31 Dec 2023 10-K 27 Mar 2025
Q4 2022 $55.1K 31 Dec 2022 10-K 16 Apr 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.